ARCHIVES

STI-571 Effects Are Lasting Against GI Stromal Tumors

This article is from The Cancer Letter archive.

Vol. 25 No. 7 | July 26, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

March 20, 1992

In Brief: Armitage Appointed to NCAB; UT Board Approves New Clinical Building for MDACC

May 19, 2000

Six NY Institutes Form Cancer Vaccine Collaboration

November 8, 2002

Are Lab Budgets Excessive? Views On Intramural Program

April 21, 1995

In Brief: ONS Invites Proposals For Research On Hazards Of Chemotherapy; UTSCC Adopts Code Of Ethics

August 31, 1984

President Obama Signs Recalcitrant Cancer Bill

January 4, 2013